EP0909558A3 - Ophthalmische Lösung enthaltend ein Chromanderivat - Google Patents
Ophthalmische Lösung enthaltend ein Chromanderivat Download PDFInfo
- Publication number
- EP0909558A3 EP0909558A3 EP98115893A EP98115893A EP0909558A3 EP 0909558 A3 EP0909558 A3 EP 0909558A3 EP 98115893 A EP98115893 A EP 98115893A EP 98115893 A EP98115893 A EP 98115893A EP 0909558 A3 EP0909558 A3 EP 0909558A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- ophthalmic solution
- active ingredient
- chroman
- derivative containing
- chroman derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940054534 ophthalmic solution Drugs 0.000 title abstract 3
- 239000002997 ophthalmic solution Substances 0.000 title abstract 3
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 3
- WAAPEIZFCHNLKK-UFBFGSQYSA-N (2s,4s)-6-fluoro-2',5'-dioxospiro[2,3-dihydrochromene-4,4'-imidazolidine]-2-carboxamide Chemical compound C([C@H](OC1=CC=C(F)C=C11)C(=O)N)[C@@]21NC(=O)NC2=O WAAPEIZFCHNLKK-UFBFGSQYSA-N 0.000 abstract 2
- 229920003174 cellulose-based polymer Polymers 0.000 abstract 2
- 230000035515 penetration Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical group OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 230000003204 osmotic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP233990/97 | 1997-08-29 | ||
| JP23399097 | 1997-08-29 | ||
| JP23399097 | 1997-08-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0909558A2 EP0909558A2 (de) | 1999-04-21 |
| EP0909558A3 true EP0909558A3 (de) | 1999-10-27 |
Family
ID=16963824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98115893A Withdrawn EP0909558A3 (de) | 1997-08-29 | 1998-08-24 | Ophthalmische Lösung enthaltend ein Chromanderivat |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0909558A3 (de) |
| KR (1) | KR19990023971A (de) |
| CN (1) | CN1215591A (de) |
| CA (1) | CA2246224A1 (de) |
| TW (1) | TW422705B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2839847C (en) * | 2003-06-13 | 2016-03-15 | Masood A. Chowhan | Ophthalmic compositions containing a synergistic combination of two polymers |
| US7358255B2 (en) * | 2003-10-24 | 2008-04-15 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctival disorder |
| IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0437025A2 (de) * | 1990-01-12 | 1991-07-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren |
| JPH03271291A (ja) * | 1990-03-19 | 1991-12-03 | Sanwa Kagaku Kenkyusho Co Ltd | 点眼剤 |
| EP0719556A2 (de) * | 1994-12-28 | 1996-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Mittel zur Behandlung von Keratopathie |
-
1998
- 1998-08-24 EP EP98115893A patent/EP0909558A3/de not_active Withdrawn
- 1998-08-27 CN CN98119985A patent/CN1215591A/zh active Pending
- 1998-08-27 CA CA002246224A patent/CA2246224A1/en not_active Abandoned
- 1998-08-28 KR KR1019980035094A patent/KR19990023971A/ko not_active Withdrawn
- 1998-08-28 TW TW087114277A patent/TW422705B/zh active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0437025A2 (de) * | 1990-01-12 | 1991-07-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren |
| JPH03271291A (ja) * | 1990-03-19 | 1991-12-03 | Sanwa Kagaku Kenkyusho Co Ltd | 点眼剤 |
| EP0719556A2 (de) * | 1994-12-28 | 1996-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Mittel zur Behandlung von Keratopathie |
Non-Patent Citations (1)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 116, no. 18, 4 May 1992, Columbus, Ohio, US; abstract no. 181154, XP002110823 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1215591A (zh) | 1999-05-05 |
| TW422705B (en) | 2001-02-21 |
| KR19990023971A (ko) | 1999-03-25 |
| CA2246224A1 (en) | 1999-02-28 |
| EP0909558A2 (de) | 1999-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2242986A1 (en) | Sustained release drug formulations | |
| WO1997028827A1 (fr) | Composition ophtalmique possedant une viscosite adaptee | |
| CA2312710A1 (en) | Sustained release formulation containing three different types of polymers and tablet formed therefrom | |
| WO1997048385A3 (en) | Controlled release tablet | |
| EP1695708A3 (de) | Pharmazeutische Zusammenstellungen | |
| EP1842567A3 (de) | Intraluminale Vorrichtung mit einer therapeutisches Mittel enthaltenden Beschichtung | |
| AU6928596A (en) | Heterocyclically substituted biphenylamide derivatives, their preparation and their use as fungicides | |
| CA2243201A1 (en) | Process for producing sustained-release preparation | |
| IE790088L (en) | Thienohydantoin derivatives | |
| CA2236262A1 (en) | Room temperature sterilant for medical devices | |
| KR960028918A (ko) | 국소용 약제학적 조성물 | |
| CA2011956A1 (en) | Sodium hyaluronate composition | |
| WO1996026718A3 (en) | Controlled release tablet | |
| AU2494097A (en) | Preparation of aqueous polymer dispersions of low viscosity with polymer volume concentrations of at least 50 per cent | |
| EP0505572A4 (en) | Iridoide derivative and its use as medicine | |
| IE811654L (en) | Ophthalmic composition | |
| AU2002357972A1 (en) | Heparin-containing ophthalmic agent | |
| EP0909558A3 (de) | Ophthalmische Lösung enthaltend ein Chromanderivat | |
| AU6086099A (en) | N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors | |
| IL131663A0 (en) | Ophthalmic composition | |
| WO1998039293A3 (en) | 13-thia prostaglandins for use in glaucoma therapy | |
| ES2080031T1 (es) | Preparacion oftalmologica. | |
| AU1413799A (en) | Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby | |
| IL109532A (en) | Compositions comprising coumarin derivatives in the form of solid dispersions | |
| NO963130L (no) | Preparat for behandling av glaukom, omfattende pilokarpin og en betablokker |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| 17P | Request for examination filed |
Effective date: 20000306 |
|
| AKX | Designation fees paid |
Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 20000629 |